A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma
Clinical trial NCT05634577 · TERMINATED
Trial details
- NCT number
- NCT05634577
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-23
- Primary completion
- 2024-07-10
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.